Skip to content
2000
Volume 16, Issue 18
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Dry powder inhalers (DPI) attracted the attention of pharmaceutical field due to its enlarging market share in inhalable formulations. These formulations also pose patient compliance and good shelf life. Earlier DPI formulations were intended for local effect in lung (asthma and chronic obstructive pulmonary diseases), whereas 21st century witnessed formulations intended for systemic effect too. A better understanding of physiology of lung and fluidics of air flow helped in targeting alveoli using DPI technology. Modern characterization tools also accelerated the research pace. In addition to the synthetic molecules, DPI also was proved to be a better system for delivering biological molecules including vaccines. This review includes the mechanisms of drug deposition, advancements in the fields of DPI devices, various characterization tools and particle engineering. In this review we have related the chronological advancement of inhalational technology starting from 1788 AD to the present.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026616666160215154938
2016-07-01
2025-07-04
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026616666160215154938
Loading

  • Article Type:
    Research Article
Keyword(s): DPI; Hypothesis II; Inhalation; Nanotechnology; Particle Engineering
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test